Previous Article | Next Article ![]()
Infect. Immun., 03 1995, 799-803, Vol 63, No. 3
D Kong and DY Kunimoto
The human interleukin 2 (huIL-2) gene was introduced into Mycobacterium
bovis BCG by using the integrative vector pMV306. To express and secrete
huIL-2 from BCG, two different plasmids, CI and CII, were made. In CI, the
huIL-2-encoding region was under the control of the alpha- antigen promoter
of BCG; in CII, the expression of huIL-2 was regulated by the heat shock
protein 60 promoter. A signal peptide sequence isolated from the naturally
secreted alpha-antigen of BCG was inserted between the promoter and
huIL-2-encoding region to facilitate secretion. Both huIL-2 expression
plasmids were integrated into the BCG genome when introduced into the BCG
Pasteur strain by electroporation. Approximately 150 U of huIL-2 was
secreted into the medium of a BCG-CII culture, while the BCG-CI cells
secreted approximately one-sixth of that amount. When the IL-2-expressing
BCG strain BCG-CII was injected intravenously into BALB/c mice, the number
of BCG cells in the spleens of these mice was significantly less than the
number in the control mice. The decreased number of IL-2-expressing BCG
cells is likely due to the augmentation of the host immune response by the
secreted huIL-2, although the exact mechanism is not known.
Copyright © 1995, American Society for Microbiology
Secretion of human interleukin 2 by recombinant Mycobacterium bovis BCG
Department of Medical Microbiology and Infectious Diseases, University of Alberta, Edmonton, Canada.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|